Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ABCC4
REST API REST API
Homo sapiens
ABCC4 is differentially expressed in 309 experiments: 111 organism parts: kidney, prostate, ... (109 more);, 194 disease states: normal, prostate carcinoma, ... (192 more);, 109 cell types 404 cell lines 35 compound treatments and 66 other conditions.
Synonyms MOATB, MRP4, EST170205, MOAT-B
Orthologs Abcc4 (Rattus norvegicus)   ENSBTAG00000023309 (Bos taurus)   ENSBTAG00000039714 (Bos taurus)   F1P043_CHICK (Gallus gallus)   ENSBTAG00000026070 (Bos taurus)   F1M3F0_RAT (Rattus norvegicus)   abcc4 (Danio rerio)   ENSBTAG00000032603 (Bos taurus)   Abcc4 (Mus musculus)   YCF1 (Saccharomyces cerevisiae)   F1M3J4_RAT (Rattus norvegicus)   CG5789 (Drosophila melanogaster)   l(2)03659 (Drosophila melanogaster)   CG10505 (Drosophila melanogaster)   CG31793 (Drosophila melanogaster)   CG31792 (Drosophila melanogaster)   CG4562 (Drosophila melanogaster)   CG11897 (Drosophila melanogaster)   CG11898 (Drosophila melanogaster)   CG9270 (Drosophila melanogaster)   F6T8N6_CIOIN (Ciona intestinalis)   CG7627 (Drosophila melanogaster)   abcc4 (Xenopus laevis)   ENSBTAG00000046041 (Bos taurus)   ENSBTAG00000047181 (Bos taurus)   ENSBTAG00000047383 (Bos taurus)   ENSBTAG00000045580 (Bos taurus)   ENSBTAG00000046611 (Bos taurus)   ENSBTAG00000045751 (Bos taurus)   B8K1W7_CANFA (Canis familiaris)   Mrp4 (Drosophila melanogaster)   (Compare orthologs)
Gene Ontology Term plasma membrane, transport, nucleoside-triphosphatase activity, chloride channel activity, ion transport, membrane, ATPase activity, blood coagulation, membrane fraction, biological_process, ATP binding, ATPase activity, coupled to transmembrane movement of substances, nucleotide binding, integral to membrane, transmembrane transport, platelet degranulation, 15-hydroxyprostaglandin dehydrogenase (NAD+) activity, platelet dense granule membrane, platelet activation
InterPro Term ATPase_AAA+_core, CysFib_conduc_TM, ABC_transporter-like, ABC_transptr_TM_dom, ABC_transporter_type1
UniProt Accession O15439, Q8IVZ4, Q8IUA3, B7Z3Q7
Search EB-eye ENSG00000125257
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-6573, E-GEOD-3526, E-MTAB-62, E-GEOD-8167, ... (25 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-MEXP-1006, E-GEOD-19639, ... (43 experiments)

Factor Value U/D Experiments
MCF-7
4
E-GEOD-20081, E-GEOD-3529, E-GEOD-5823, E-GEOD-19639
BT474
3
E-MTAB-37, E-MEXP-440, E-MTAB-62
A549
2
E-GEOD-6013, E-GEOD-3202
BT20
2
E-MTAB-37, E-MTAB-62
SW620
2
E-MTAB-37, E-GEOD-2509
WI38
2
E-MTAB-37, E-MTAB-62
398 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-20677, E-TABM-34, E-GEOD-2822, E-GEOD-21909, ... (56 experiments)

Factor Value U/D Experiments
stromal cell
1
3
E-MEXP-2034, E-MEXP-1327, E-GEOD-1460, E-GEOD-3998
721 B lymphoblast
2
E-AFMX-5, E-TABM-145
embryonic stem cell
1
2
E-MEXP-930, E-GEOD-2248, E-GEOD-26672
naive T cell
1
E-GEOD-1460
astrocyte
1
E-GEOD-4483
germ cell
1
E-MTAB-25
103 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-GEOD-16363, E-MTAB-62, ... (64 experiments)

Factor Value U/D Experiments
prostate carcinoma
5
E-MTAB-62, E-GEOD-7307, E-MEXP-1327, E-TABM-26, E-MTAB-37 ... (5 experiments)
chronic myelogenous leukemia
4
E-GEOD-5550, E-MTAB-62, E-GEOD-96, E-MTAB-37
cervical carcinoma
3
E-MTAB-37, E-MTAB-62, E-GEOD-5823
septic shock
2
E-GEOD-8121, E-GEOD-9692
acute promyelocytic leukemia
2
E-MTAB-62, E-GEOD-1729
adrenocortical carcinoma
2
E-TABM-311, E-GEOD-10927
188 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-5741, E-TABM-782, E-GEOD-5824, E-TABM-868, ... (25 experiments)

Factor Value U/D Experiments
lipopolysaccharide
2
E-TABM-868, E-MEXP-1958
glucose
1
E-MEXP-941
AMP
1
1
E-MEXP-2285
unknown
1
E-GEOD-7307
ox-LDL
1
E-GEOD-5741
NaOH
1
1
E-MEXP-2590
29 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
thapsigargin
1
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-GEOD-1729

Clinical history
studied in E-GEOD-22097, E-GEOD-19420, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-19348, E-MEXP-1251, ... (10 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-1614, E-GEOD-20033, E-GEOD-3140, E-GEOD-6236, ... (8 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-7788, E-GEOD-3325, E-GEOD-2509, E-TABM-147, ... (9 experiments)

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643

Erbb2
studied in E-GEOD-21653

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-1643

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-GEOD-7011, E-MTAB-73, E-MEXP-1482, E-GEOD-7578, ... (9 experiments)

Genotype
studied in E-TABM-1029, E-GEOD-17476, E-GEOD-2466, E-GEOD-22593, E-TABM-868, ... (15 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-GEOD-7011, E-MEXP-2657, E-GEOD-837, E-MEXP-1273, ... (14 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-GEOD-16194, E-TABM-276, E-GEOD-20194, E-GEOD-16716, E-GEOD-2748 ... (5 experiments)

Individual
studied in E-TABM-325, E-MTAB-197, E-TABM-740, E-MEXP-2069, E-GEOD-1926, ... (32 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-12108, E-GEOD-17400, E-GEOD-6802

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214, E-GEOD-12662

Material type
studied in E-MEXP-455, E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Phenotype
studied in E-GEOD-7819, E-GEOD-22309, E-GEOD-21750, E-GEOD-1460, E-GEOD-17636, ... (6 experiments)

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19246

Replicate
studied in E-GEOD-18791, E-GEOD-10896

RNAi
studied in E-MEXP-2115, E-MEXP-101, E-MEXP-1857, E-MEXP-2759

Sample preparation
studied in E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-MEXP-70, E-GEOD-17400

Sex
studied in E-GEOD-2466, E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

Strain or line
studied in E-MEXP-1996

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Test result
studied in E-TABM-276, E-GEOD-2748

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-19246, E-GEOD-13818, E-GEOD-12198

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-TABM-147

Processing time: 0.303 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM